Search
My Stocks
SGX
Google
Yahoo
News
TradingView
IX BIOPHARMA LTD. (42C)
SGD 0.129
-4.65% -0.01
Portfolio
Watchlist
Divs
Anns
Trans
Notes
Articles
All
Financial
Buy Back
Insider Trading
2025-10-31
General Announcement::Press Release - iX Biopharma Raises S$6.7 Million to Accelerate U.S. Expansion
2025-10-30
Placements::Proposed Placement To Raise Gross Proceeds No Less Than S$5 Million - Receipt of LQN
2025-10-28
Placements::Proposed Placement To Raise Gross Proceeds No Less Than S$5 Million - Results of Proposed Placement
2025-10-28
General Announcement::Proposed Placement To Raise Gross Proceeds No Less Than S$5 Million - Entry Into Placement Agreement
2025-10-27
Equity Listing - Ordinary Shares::Issue and Allotment of Shares Pursuant to Exercise of Warrants
2025-10-24
REPL::Annual General Meeting::Voluntary
2025-10-22
Equity Listing - Ordinary Shares::Issue and Allotment of Shares Pursuant to Exercise of Warrants
2025-10-07
Annual General Meeting::Voluntary
2025-08-29
Financial Statements and Related Announcement::Full Yearly Results
2025-07-03
Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer::Disclosure of Interest/ Changes in Interest of Director - Eddy Lee Yip Hang
2025-03-24
Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer::Disclosure of Interest/ Changes in Interest of Director - Patrick Donald Davies
2025-03-24
Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer::Disclosure of Interest/ Changes in Interest of Director - Teo Woon Keng John
2025-03-24
Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer::Disclosure of Interest/ Changes in Interest of Director - Albert Ho Shing Tung
2025-03-21
General Announcement::Issuance and Allotment of Directors' Shares
2025-03-10
REPL::Extraordinary/ Special General Meeting::Voluntary
2025-02-22
Extraordinary/ Special General Meeting::Voluntary
2025-02-21
Equity Listing - Ordinary Shares::Issue and Allotment of New Shares Pursuant to iX Performance Share Plan
2025-02-14
Employee Stock Option/ Share Scheme::Grant of Share Awards Pursuant to iX Performance Share Plan
2025-02-07
Financial Statements and Related Announcement::Half Yearly Results
2024-11-15
General Announcement::Minutes of Annual General Meeting Held on 17 October 2024
2024-10-17
REPL::Annual General Meeting::Voluntary
2024-10-17
REPL::Extraordinary/ Special General Meeting::Voluntary
2024-09-30
Financial Statements and Related Announcement::Auditor's Comments of Accounts
2024-09-30
Annual General Meeting::Voluntary
2024-09-30
Change - Announcement of Cessation::Retirement of Independent Director
2024-09-30
Extraordinary/ Special General Meeting::Voluntary
2024-08-12
General Announcement::Press Release - New Study Highlights CBD Wafer's Potential in Kidney Failure Patients
2024-07-24
Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer::Disclosure of Interest/ Changes in Interest of Director - Albert Ho Shing Tung
2024-07-22
REPL::Rights::Voluntary
2024-07-19
General Announcement::Issue and Listing of the Rights Shares and the Warrants
2024-07-15
General Announcement::Notice From Undertaking Shareholder Anson Properties Pte. Ltd.
2024-07-09
General Announcement::Press Release - Breakthrough Sublingual Wafers Raise NAD+ Levels, Enhance Well-Being in Human Trial
2024-07-02
Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer::Disclosure of Interest/ Changes in Interest of Director - Albert Ho Shing Tung
2024-07-02
Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer::Disclosure of Interest/ Changes in Interest of Director - Eddy Lee Yip Hang
2024-07-01
General Announcement::Proposed Renounceable Non-Underwritten Rights Cum Warrants Issue: Despatch of Notification and Forms
2024-06-26
REPL::Rights::Voluntary
2024-06-18
General Announcement::Notice of Adjustment to Conversion Price of 9% Convertible Bonds Principal Amount S$2 Million
2024-06-18
REPL::Rights::Voluntary
2024-06-11
REPL::Rights::Voluntary
2024-06-06
Rights::Voluntary
2024-03-20
General Announcement::Update For Shareholders
2024-03-11
General Announcement::Press Release - iX Biopharma Announces Development of Semaglutide Sublingual Wafer, iXB 401
2024-03-04
General Announcement::Press Release - iX Biopharma Unveils Novel NAD Wafers
2024-03-01
General Announcement::Termination Of Wafermine Licensing Agreement
2024-02-05
Financial Statements and Related Announcement::Half Yearly Results
2023-12-01
Employee Stock Option/ Share Scheme::Grant of Share Awards Pursuant to iX Performance Share Plan
2023-11-17
General Announcement::Notice Of Termination Of Wafermine Licensing Agreement
2023-11-14
General Announcement::Change of Address of Share Registrar and Place Where Register of Members and Index Is Kept
2023-11-10
General Announcement::Minutes of Annual General Meeting Held on 13 October 2023
2023-10-13
REPL::Annual General Meeting::Voluntary
«
Previous
1
2
3
4
5
»
Next
© 2025 Dividends.sg /
More Countries
© Owned by Little White Pte. Ltd.